Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ISOFOL.ST
- Price
- 1.77
- Stock movement down
- -0.01 (-0.62%)
- Company name
- Isofol Medical AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 285.72M
- Ent value
- 200.73M
- Price/Sales
- -
- Price/Book
- 3.14
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -31.07%
- 1 year return
- 134.93%
- 3 year return
- -42.90%
- 5 year return
- -28.03%
- 10 year return
- -
Last updated: 2025-04-15
DIVIDENDS
ISOFOL.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 3.14 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 161.52M |
| EPS (TTM) | -0.24 |
| FCF per share (TTM) | -0.25 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -9.68M |
| Operating income (TTM) | -43.63M |
| Net income (TTM) | -39.27M |
| EPS (TTM) | -0.24 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 104.02M |
| Net receivables | 0.00 |
| Total current assets | 110.07M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 110.07M |
| Accounts payable | 1.08M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 18.40M |
| Total liabilities | 19.03M |
| Shareholder's equity | 91.05M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -40.74M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -40.74M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -43.13% |
| Return on Assets | -35.68% |
| Return on Invested Capital | -43.13% |
| Cash Return on Invested Capital | -44.75% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.78 |
| Daily high | 1.81 |
| Daily low | 1.74 |
| Daily Volume | 97K |
| All-time high | 33.00 |
| 1y analyst estimate | 0.77 |
| Beta | 1.89 |
| EPS (TTM) | -0.24 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 8 May 2025 |
Downside potential
Loading...
Downside potential data
| ISOFOL.ST | S&P500 | |
| Current price drop from All-time high | -94.64% | -12.04% |
| Highest price drop | -98.51% | -56.47% |
| Date of highest drop | 2 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -58.74% | -11.07% |
| Avg time to new high | 169 days | 12 days |
| Max time to new high | 1077 days | 1805 days |
COMPANY DETAILS
Marketcap
285.72M
Marketcap category
Small-cap
Description
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As the European markets navigate the complexities of U.S. trade policy uncertainties, recent economic measures by Germany and the European Union have provided some stability amidst volatility. Penny s...
March 14, 2025
As global markets navigate a landscape of shifting interest rates and economic indicators, the Nasdaq Composite has defied broader declines by reaching new highs. In such a climate, penny stocks—often...
December 19, 2024
As global markets navigate the uncertainties surrounding the incoming Trump administration, investors are keeping a close eye on sector-specific movements and regulatory changes. Amidst these fluctuat...
November 20, 2024